Granuloma Annulare Exhibits Mixed Immune and Macrophage Polarization Profiles with Spatial Transcriptomics
- PMID: 38844128
- DOI: 10.1016/j.jid.2024.04.024
Granuloma Annulare Exhibits Mixed Immune and Macrophage Polarization Profiles with Spatial Transcriptomics
Abstract
Granuloma annulare (GA) is an idiopathic condition characterized by granulomatous inflammation in the skin. Prior studies have suggested that GA develops from various triggers, leading to a complex interplay involving innate and adaptive immunity, tissue remodeling, and fibrosis. Macrophages are the major immune cells comprising GA granulomas; however, the molecular drivers and inflammatory signaling cascade behind macrophage activation are poorly understood. Histologically, GA exhibits both palisaded and interstitial patterns on histology; however, the molecular composition of GA at the spatial level remains unexplored. GA is a condition without Food and Drug Administration-approved therapies despite the significant impact of GA on QOL. Spatial transcriptomics is a valuable tool for profiling localized, genome-wide gene expression changes across tissues, with emerging applications in clinical medicine. To improve our understanding of the spatially localized gene expression patterns underlying GA, we profiled the spatial gene expression landscape from 6 patients with GA. Our findings revealed mixed T helper 1 and T helper 2 signals comprising the GA microenvironment and spatially distinct M1 and M2 macrophage polarization characteristics. IFN-γ and TNF signals emerged as important regulators of GA granulomatous inflammation, and IL-32 emerged as a key driver of granulomatous inflammation. Overall, our spatial transcriptomics data indicate that GA exhibits mixed immune and macrophage polarization.
Keywords: Granuloma annulare; Granulomas; IFN-γ; Macrophage; TNF.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Granuloma annulare skin profile shows activation of T-helper cell type 1, T-helper cell type 2, and Janus kinase pathways.J Am Acad Dermatol. 2020 Jul;83(1):63-70. doi: 10.1016/j.jaad.2019.12.028. Epub 2019 Dec 20. J Am Acad Dermatol. 2020. PMID: 31870914
-
Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib.J Allergy Clin Immunol. 2021 May;147(5):1795-1809. doi: 10.1016/j.jaci.2020.10.012. Epub 2020 Dec 11. J Allergy Clin Immunol. 2021. PMID: 33317858 Clinical Trial.
-
Histopathologic Aspects of Malignancy-Associated Granuloma Annulare: A Single Institution Experience.Dermatopathology (Basel). 2023 Mar 4;10(1):95-103. doi: 10.3390/dermatopathology10010015. Dermatopathology (Basel). 2023. PMID: 36975384 Free PMC article.
-
Cutaneous Granulomatosis: a Comprehensive Review.Clin Rev Allergy Immunol. 2018 Feb;54(1):131-146. doi: 10.1007/s12016-017-8666-8. Clin Rev Allergy Immunol. 2018. PMID: 29352388 Review.
-
Granuloma Annulare.Dermatol Clin. 2015 Jul;33(3):315-29. doi: 10.1016/j.det.2015.03.001. Epub 2015 May 13. Dermatol Clin. 2015. PMID: 26143416 Review.
LinkOut - more resources
Full Text Sources
